Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 23 04:00PM ET
8.00
Dollar change
-0.25
Percentage change
-3.03
%
Index- P/E- EPS (ttm)-0.08 Insider Own57.59% Shs Outstand4.79M Perf Week-9.95%
Market Cap38.20M Forward P/E- EPS next Y- Insider Trans0.13% Shs Float2.06M Perf Month-19.68%
Income- PEG- EPS next Q- Inst Own1.53% Short Float0.43% Perf Quarter0.07%
Sales0.18M P/S215.34 EPS this Y- Inst Trans- Short Ratio2.66 Perf Half Y-20.32%
Book/sh6.33 P/B1.26 EPS next Y- ROA- Short Interest0.01M Perf Year-12.28%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range7.11 - 13.13 Perf YTD-16.67%
Dividend Est.- P/FCF- EPS past 5Y125.02% ROI- 52W High-39.06% Beta-0.48
Dividend TTM- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low12.52% ATR (14)0.49
Dividend Ex-DateJan 05, 2018 Current Ratio- EPS Y/Y TTM- Oper. Margin- RSI (14)38.21 Volatility8.47% 4.83%
Employees- Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom2.00 Target Price23.00
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q- Payout- Rel Volume0.54 Prev Close8.25
Sales Surprise- EPS Surprise- Sales Q/Q-40.10% Earnings- Avg Volume3.35K Price8.00
SMA20-8.66% SMA50-8.25% SMA200-15.88% Trades Volume1,806 Change-3.03%
Date Action Analyst Rating Change Price Target Change
May-16-19Initiated Ascendiant Capital Markets Buy $20
Feb-12-24 08:00AM
Feb-07-24 08:00AM
Jan-29-24 08:00AM
Jan-16-24 08:00AM
Jan-09-24 08:00AM
08:30AM Loading…
Jan-02-24 08:30AM
Nov-13-23 08:00AM
Nov-09-23 08:00AM
Oct-13-23 08:00AM
Oct-11-23 08:00AM
Oct-04-23 08:00AM
Sep-27-23 08:00AM
Sep-26-23 08:00AM
Sep-11-23 12:00PM
Sep-07-23 09:15AM
04:15PM Loading…
Aug-28-23 04:15PM
04:05PM
Aug-10-23 08:00AM
Jul-12-23 08:00AM
Jul-11-23 08:00AM
Jul-05-23 08:00AM
Jun-22-23 04:15PM
Jun-20-23 08:00AM
Jun-15-23 08:00AM
Jun-12-23 08:00AM
May-25-23 03:37PM
May-22-23 08:30AM
May-19-23 04:53PM
May-18-23 08:00AM
Apr-20-23 08:00AM
08:00AM Loading…
Apr-17-23 08:00AM
Apr-13-23 08:00AM
Mar-27-23 08:00AM
Mar-23-23 08:30AM
08:00AM
Mar-03-23 08:00AM
Mar-02-23 07:00AM
Mar-01-23 08:00AM
Feb-17-23 08:00AM
Jan-19-23 08:00AM
Jan-13-23 08:00AM
Jan-03-23 08:00AM
Nov-17-22 11:07AM
Nov-15-22 08:45AM
Nov-14-22 05:03PM
Nov-10-22 08:00AM
Nov-03-22 08:00AM
Oct-31-22 08:00AM
Oct-05-22 08:30AM
Oct-04-22 08:30AM
08:00AM
Oct-03-22 09:00AM
08:40AM
08:00AM
Sep-26-22 08:00AM
Sep-06-22 05:05PM
Aug-29-22 08:00AM
Aug-25-22 04:05PM
Aug-24-22 04:40PM
Jul-27-22 08:00AM
Jul-21-22 08:00AM
Jul-18-22 08:00AM
Jun-27-22 08:00AM
Jun-13-22 08:00AM
May-25-22 08:00AM
May-12-22 08:00AM
May-02-22 08:00AM
Apr-06-22 08:00AM
Mar-23-22 08:00AM
Mar-01-22 09:00AM
08:00AM
Feb-17-22 08:00AM
Feb-02-22 08:00AM
Jan-21-22 08:00AM
Jan-20-22 04:05PM
Jan-06-22 08:00AM
Jan-05-22 08:00AM
Jan-04-22 08:00AM
Nov-16-21 08:00AM
Nov-09-21 08:00AM
Oct-01-21 08:30AM
Sep-14-21 08:30AM
Sep-08-21 08:30AM
Sep-07-21 08:30AM
Sep-01-21 08:30AM
Aug-30-21 08:30AM
Aug-04-21 08:30AM
Jul-22-21 08:30AM
Jul-13-21 08:30AM
May-28-21 08:30AM
May-27-21 07:15PM
May-13-21 08:30AM
May-06-21 08:30AM
Apr-29-21 08:31AM
Mar-25-21 11:25AM
Mar-18-21 08:30AM
Mar-16-21 08:30AM
Mar-15-21 08:30AM
Mar-04-21 08:30AM
Feb-27-21 02:39AM
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Michel Robert JChief Financial OfficerDec 06Buy7.7512093010,550Dec 06 03:48 PM
Feldschuh Michael RichardChief Executive OfficerDec 01Buy7.808006,240162,492Dec 01 08:58 PM
Michel Robert JChief Financial OfficerDec 01Buy7.751801,39510,430Dec 01 09:00 PM
Michel Robert JChief Financial OfficerNov 24Buy7.945003,97010,250Nov 27 06:03 AM
Feldschuh Michael RichardCHIEF EXECUTIVE OFFICERNov 10Buy7.831,0017,838161,608Nov 13 06:33 AM
Feldschuh Michael RichardCHIEF EXECUTIVE OFFICERNov 09Buy7.854013,148160,607Nov 13 06:33 AM
Michel Robert JChief Financial OfficerOct 13Buy9.025004,5107,750Oct 16 12:41 PM
Feldschuh Michael RichardCEO & PresidentMay 24Buy9.752,00019,500160,206May 25 03:52 PM
Goudie Joy S.DirectorMay 24Buy9.753002,925300May 25 03:49 PM